| 2020 |
ATG9A is a lipid scramblase that equilibrates phospholipids across membrane bilayers in vitro. Cryo-EM structures reveal a homotrimeric architecture with a solvated central pore connected laterally to the cytosol through cavities within each protomer. Molecular dynamics simulations suggest the central pore opens laterally to accommodate lipid headgroups, enabling lipid flipping. Mutations in the pore reduce scrambling activity and yield markedly smaller autophagosomes, establishing that lipid scrambling by ATG9A is essential for autophagosome membrane expansion. |
Cryo-EM structure determination, in vitro lipid scrambling assay, molecular dynamics simulation, mutagenesis with functional readout (autophagosome size) |
Nature structural & molecular biology |
High |
33106659
|
| 2020 |
Cryo-EM structure of human ATG9A at 2.9-Å resolution reveals a homotrimeric domain-swapped architecture, multiple membrane spans, and a network of branched cavities consistent with a membrane transporter function. Mutational analyses support a role for the cavities in ATG9A function. Structure-guided molecular simulations predict ATG9A causes membrane bending, explaining its localization to small vesicles and highly curved autophagosome edges. |
Cryo-EM structure determination (2.9 Å), mutagenesis, molecular dynamics simulation |
Cell reports |
High |
32610138
|
| 2022 |
ATG9A and ATG2A form a heteromeric complex essential for autophagosome formation. Using peptide arrays, crosslinking, hydrogen-deuterium exchange mass spectrometry, and cryo-EM, several interfaces mediating ATG9A–ATG2A interaction were identified. The model proposes direct lipid transfer from ATG2A into the lipid-binding perpendicular branch of ATG9A. Mutational analyses of these interfaces combined with functional autophagy assays confirmed their importance. |
Peptide arrays, crosslinking MS, HDX-MS, cryo-EM, mutagenesis + functional autophagy assays |
Molecular cell |
High |
36347259
|
| 2024 |
Cryo-EM structures of human ATG2A–WIPI4 (3.2 Å) and ATG2A–WIPI4–ATG9A (7 Å) complexes reveal a 3:1 stoichiometry of ATG9A trimer to ATG2A, with the ATG9A lateral pore directly aligned with the ATG2A lipid transfer cavity. The ATG9A trimer contacts both the N-terminal and C-terminal tip of rod-shaped ATG2A. Cryo-electron tomography showed ATG2A tethers lipid vesicles at different orientations, and MD simulations propose a mechanism for lipid extraction from donor membranes. |
Cryo-EM structure determination, cryo-electron tomography, molecular dynamics simulation |
Nature structural & molecular biology |
High |
39174844
|
| 2023 |
X-ray crystallographic structure (2.4 Å) of the ATG9A C-terminal tail bound to the ATG13–ATG101 HORMA dimer reveals a 'HORMA dimer-interacting region' (HDIR) in the extreme C-terminus of ATG9A. The HDIR binds the HORMA domain of ATG101 by β-sheet complementation, occupying a deep cleft at the ATG13–ATG101 interface. Disruption of this complex in cells impairs PINK1/Parkin-dependent mitophagy mediated by cargo receptor NDP52. |
X-ray crystallography (2.4 Å), cell-based mitophagy assays with structure-guided mutants |
Science advances |
High |
36791199
|
| 2009 |
ATG9A co-localizes with STING and LC3 after dsDNA stimulation. Loss of Atg9a (but not Atg7) greatly enhances STING–TBK1 assembly induced by dsDNA, leading to aberrant innate immune activation. Thus ATG9A negatively regulates STING–TBK1 complex formation and innate immune signaling downstream of dsDNA sensing. |
Atg9a knockout mouse macrophages, co-localization (immunofluorescence), genetic epistasis (Atg9a KO vs Atg7 KO), measurement of STING–TBK1 assembly and IFN production |
Proceedings of the National Academy of Sciences of the United States of America |
High |
19926846
|
| 2017 |
AP-4 promotes signal-mediated export of ATG9A from the trans-Golgi network (TGN) to the peripheral cytoplasm. AP-4 deficiency causes retention of ATG9A at the TGN, impairs LC3B lipidation, and blocks maturation of preautophagosomal structures. ATG9A is identified as a specific AP-4 cargo. |
AP-4 KO cells, immunofluorescence localization of ATG9A, LC3B lipidation assay, preautophagosomal structure analysis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
29180427
|
| 2018 |
AP-4 deficiency causes missorting of ATG9A in multiple cell types including patient-derived cells. RUSC2 facilitates transport of AP-4-derived ATG9A-positive vesicles from the TGN to the cell periphery. These vesicles cluster near autophagosomes, suggesting they constitute the 'ATG9A reservoir' required for autophagosome biogenesis. Dysregulation of autophagy accompanies ATG9A missorting. |
Dynamic Organellar Maps proteomics, AP-4 KO cells and patient-derived fibroblasts, immunofluorescence, RUSC2 knockdown experiments |
Nature communications |
High |
30262884
|
| 2019 |
ATG9A vesicles are enriched in BAR-domain proteins (Arfaptins) and phosphoinositide-metabolizing enzymes. Arfaptin2 regulates starvation-dependent distribution of ATG9A vesicles. ATG9A vesicles deliver PI4-kinase PI4KIIIβ to the autophagosome initiation site. PI4KIIIβ interacts with both ATG9A and ATG13 to control PI4P production at the initiation membrane and the autophagic response. |
Quantitative proteomics of immunoisolated ATG9A vesicles, Co-IP (ATG9A–PI4KIIIβ–ATG13), siRNA knockdown, PI4P production assay |
The Journal of cell biology |
High |
30917996
|
| 2020 |
The autophagy adaptor OPTN forms a complex with ATG9A vesicles. Disruption of OPTN–ATG9A interactions prevents mitophagy. OPTN–ATG9A interaction is required for de novo synthesis of autophagosomal membranes near ubiquitinated mitochondria, defining an OPTN–ATG9A axis for mitophagy initiation. |
Phase-separated fluorescent foci assay, Co-IP, mitophagy induction with mitochondria-targeted ubiquitin chains, disruption of OPTN–ATG9A interaction with functional readout |
The Journal of cell biology |
High |
32556086
|
| 2021 |
ATG9A depletion increases lipid droplet size and/or number and blocks fatty acid transfer from lipid droplets to mitochondria, impairing mitochondrial respiration. ATG9A localizes to vesicular-tubular clusters (VTCs) tightly associated with an ER subdomain enriched in TMEM41B and in proximity to phagophores, lipid droplets, and mitochondria, establishing a non-autophagic role for ATG9A in lipid mobilization. |
ATG9A KO in human cell lines and C. elegans, lipid droplet imaging, fatty acid transfer assay (fluorescent lipid tracking), mitochondrial respiration assay, immunofluorescence localization |
Nature communications |
High |
34799570
|
| 2021 |
ATG9A organizes, together with IQGAP1, components of the ESCRT system at the plasma membrane (PM). ATG9A and ESCRTs cooperate to protect the PM from damage by a broad spectrum of agents including gasdermin, MLKL, and coronavirus ORF3a. ATG9A KO sensitizes the PM to permeabilization. |
ATG9A KO cells, ESCRT co-localization/interaction studies, PM permeabilization assays with multiple agents, IQGAP1 interaction experiments |
Nature cell biology |
High |
34257406
|
| 2025 |
ATG9A facilitates autophagosome closure by partnering with IQGAP1 and the key ESCRT-III component CHMP2A. This function is distinct from its roles in phagophore initiation and expansion, making ATG9A a central hub governing all major stages of autophagosome membrane biogenesis. |
Co-IP (ATG9A–IQGAP1–CHMP2A), KO cells with autophagosome closure assay (SolVit), high-content microscopy |
The Journal of cell biology |
High |
39745851
|
| 2022 |
TRAF6 E3 ubiquitin ligase mediates K48/K63-linked non-proteolytic ubiquitination of ATG9A in response to ROS. A20 deubiquitinase reverses this modification. Ubiquitinated ATG9A shows enhanced association with Beclin 1 and promotes assembly of the VPS34–UVRAG complex, stimulating autophagy. ATG9A ubiquitination mutants impair VPS34 activation and autophagy under oxidative stress. |
Ubiquitination assays (K48/K63-specific), Co-IP (ATG9A–Beclin 1–VPS34–UVRAG), TRAF6 KO/overexpression, A20 deubiquitinase assay, VPS34 activity assay |
Cell reports |
High |
35196483
|
| 2022 |
ATG9A and FIP200 promote degradation of cytotoxic TNFR1 complex IIa through an LC3-independent lysosomal targeting pathway, constituting a cell-death checkpoint that prevents TNF-induced apoptosis. This mechanism counteracts TNFR1-mediated embryonic lethality and inflammatory skin disease in mouse models. |
ATG9A KO mice, co-immunoprecipitation, lysosomal targeting assay, cell death assays, mouse embryonic lethality model, inflammatory skin disease model |
Science |
High |
36520901
|
| 2016 |
ATG9A contains AP-2-binding sorting motifs in its N-terminal cytosolic stretch. Mutations in these motifs prevent autophagy and cause abnormal accumulation of ATG9A at recycling endosomes. Knockdown of TRAPPC8 (a TRAPPIII subunit) similarly causes ATG9A accumulation in recycling endosomes and autophagy defects, demonstrating that ATG9A trafficking through recycling endosomes is essential for autophagosome formation. |
Mutagenesis of AP-2 binding motifs, immunofluorescence localization, siRNA knockdown of TRAPPC8, autophagy flux assay |
Journal of cell science |
High |
27587839
|
| 2018 |
SNX18 regulates ATG9A trafficking from recycling endosomes by recruiting Dynamin-2. ATG9A is recruited to SNX18-induced tubules from recycling endosomes and accumulates in juxtanuclear recycling endosomes in cells lacking SNX18. SNX18–Dynamin-2 binding is required for ATG9A trafficking and for formation of ATG16L1- and WIPI2-positive autophagosome precursor membranes. |
SNX18 KO/knockdown, immunofluorescence, SNX18–Dynamin-2 interaction assay, autophagosome precursor membrane quantification |
EMBO reports |
Medium |
29437695
|
| 2021 |
ATG9A interacts with ATG13 and ATG101 (ULK1 complex members) independently of ULK1. Deletion of ATG13 or ATG101 causes aberrant ATG9A accumulation at stalled p62/SQSTM1–ubiquitin clusters. This ULK1-independent ATG13 complex regulates ATG9A distribution. |
BioID quantitative proteomics, KO/reconstitution, split-mVenus interaction assay, immunofluorescence |
EMBO reports |
Medium |
34369648
|
| 2020 |
The FTS-Hook-FHIP (FHF) complex interacts with AP-4 through direct binding of the AP-4 μ4 subunit to coiled-coil domains in Hook1 and Hook2. Knockdown of FHF subunits disperses AP-4 and ATG9A from the perinuclear region, consistent with FHF coupling AP-4/ATG9A vesicles to the microtubule retrograde motor dynein-dynactin. |
Affinity purification–mass spectrometry, Co-IP (μ4–Hook1/Hook2), siRNA knockdown with ATG9A/AP-4 localization readout |
Molecular biology of the cell |
Medium |
32073997
|
| 2021 |
RUSC2 couples ATG9A-containing AP-4 vesicles to the plus-end-directed microtubule motor kinesin-1 via an interaction between a disordered region of RUSC2 and kinesin-1 light chain, driving peripheral distribution of ATG9A vesicles. WDR47 counteracts this interaction as a negative regulator. |
Co-IP (RUSC2–kinesin-1 light chain), ATG9A localization assays in KO/knockdown cells, WDR47 overexpression experiments |
Molecular biology of the cell |
Medium |
34432492
|
| 2017 |
Small GTPase Rab1B associates with ATG9A vesicles. Knockdown of Rab1B suppresses autophagy and causes ATG9A accumulation in intermediate membrane structures at autophagosome formation sites, placing Rab1B upstream of proper ATG9A-dependent autophagosome development. |
Immunoisolation of ATG9A vesicles with proteomic analysis, Rab1B siRNA knockdown, immunofluorescence of ATG9A localization |
FASEB journal |
Medium |
28522593
|
| 2018 |
In AP-4 ε KO mice, ATG9A is more concentrated in the TGN and depleted from peripheral cytoplasm in neurons. This mislocalization is associated with increased accumulation of mutant huntingtin aggregates in axons, linking AP-4-dependent ATG9A trafficking to autophagic clearance of protein aggregates in neurons. |
AP-4 ε KO mouse model, immunohistochemistry, patient fibroblast analysis, mutant HTT aggregate assay |
PLoS genetics |
Medium |
29698489
|
| 2019 |
In AP-4 KO neurons, ATG9A is retained in the TGN, depleting axonal ATG9A and causing defective axonal autophagosome generation, aberrant expansions of the distal axon, and impaired axonal extension. |
AP-4 epsilon subunit KO mouse model, immunofluorescence of ATG9A/autophagosomes, axonal morphology analysis |
Autophagy |
Medium |
31142229
|
| 2022 |
Upon heat stress, the E3 ubiquitin ligase MARCH9 ubiquitinates ATG9A via K63-linked conjugation. Non-degradable ubiquitinated ATG9A disperses from the Golgi and inhibits GRASP55 oligomerization, causing Golgi fragmentation. ATG9A KO or MARCH9 KO prevents Golgi fragmentation under heat and other Golgi stresses, revealing a non-autophagic role for ATG9A in Golgi dynamics. |
MARCH9 overexpression/KO, ubiquitination assays, ATG9A KO, GRASP55 oligomerization assay, Golgi morphology quantification |
Cell reports |
Medium |
35977480
|
| 2021 |
ATG9A acetylation within the ER lumen (regulated by AT-1/SLC33A1) controls reticulophagy induction. Despite luminal acetylation, ATG9A engages reticulophagy receptors FAM134B and SEC62 on the cytosolic side of the ER. Interactome analysis identified CALR and HSPB1 as ATG9A partners that regulate reticulophagy induction as a function of ATG9A acetylation state. |
Two mouse models of AT-1 dysregulation (overexpression and haploinsufficiency), ATG9A interactome analysis, reticulophagy assays |
iScience |
Medium |
33870132
|
| 2021 |
BECN2 recruits inflammasome sensors (NLRP3, AIM2, NLRP1, NLRC4) onto ATG9A+ vesicles forming a BECN2–ATG9A–sensor complex upon ULK1 activation, directing sensor degradation through a ULK1- and ATG9A-dependent but BECN1–WIPI2–ATG16L1–LC3-independent non-canonical autophagic pathway. SNARE proteins SEC22A, STX5, and STX6 mediate this pathway. |
BECN2 KO mice, Co-IP (BECN2–ATG9A–sensors), siRNA knockdown, inflammasome activity assays, SNARE interaction experiments |
Autophagy |
Medium |
34152938
|
| 2022 |
ATG9A plays a critical role in chemotactic migration of human cell lines including glioma cells. ATG9A-positive vesicles are targeted to the migration front of polarized cells, where their exocytosis correlates with protrusive activity. ATG9A is critical for efficient delivery of β1 integrin to the leading edge and normal adhesion dynamics. |
ATG9A siRNA depletion, TIRF live-cell microscopy of ATG9A-pHluorin construct, β1 integrin trafficking assay, lamellipodium formation quantification |
The Journal of cell biology |
Medium |
35180289
|
| 2018 |
VAMP7 localizes to ATG9A-resident vesicles at recycling endosomes. Hrb recruits VAMP7 and ATG9A from the plasma membrane to recycling endosomes. VAMP7 forms a SNARE complex with Syntaxin16 and SNAP-47, which mediates fusion of ATG9A-resident vesicles during autophagosome formation in pancreatic β-cells. |
VAMP7-deficient β-cells, Co-IP (VAMP7–Hrb–Syntaxin16–SNAP-47), immunofluorescence, siRNA knockdown of SNARE components, autophagy assay |
Endocrinology |
Medium |
30215699
|
| 2018 |
Atg9a conditional KO in mouse brain causes progressive axonal degeneration with aberrant membrane structures and accumulation of SQSTM1/p62 and NBR1 at early postnatal stages. ATG9A is also required for neurite outgrowth independently of ATG7 and ATG16L1, demonstrating an autophagy-independent function of ATG9A in neurite extension. |
Brain-specific conditional Atg9a KO mice, electron microscopy, immunohistochemistry, Western blot, primary neuronal culture neurite outgrowth assay in multiple KO backgrounds, DTI-MRI |
Autophagy |
Medium |
28513333
|
| 2016 |
Excess sphingomyelin (due to SMPD1 deficiency) causes ATG9A to concentrate in transferrin receptor-positive juxtanuclear recycling endosomes instead of its normal trafficking itinerary, impairing autophagosome maturation and closure. Ectopic ATG9A expression reverts this autophagy defect, and exogenous C12-sphingomyelin induces similar juxtanuclear ATG9A accumulation in healthy cells. |
Niemann-Pick patient fibroblasts, SMPD1 siRNA knockdown, ATG9A localization (immunofluorescence), ectopic ATG9A rescue, ceramide/sphingomyelin treatment, smpd1-KO mouse tissue |
Autophagy |
Medium |
27070082
|
| 2016 |
A conserved glycine residue (G516) in the C-terminal V515-C519 motif of human ATG9A is required for its transport from the ER to the Golgi apparatus. Mutation of this motif severely impairs ER-to-Golgi transport. ATG9A self-interacts, and this self-interaction promotes its trafficking through the Golgi, but the molecular mechanism of self-interaction differs from yeast. |
Sequential mutagenesis of V515-C519 motif, immunofluorescence localization, co-immunoprecipitation for self-interaction |
Biochemical and biophysical research communications |
Medium |
27663665
|
| 2016 |
Deletion of amino acids L340–L354 causes ER retention of ATG9A. Mutation of the L711YM713 sequence in the C-terminal region impairs ATG9A transport through the Golgi. Some newly synthesized ATG9A can bypass the Golgi to reach the plasma membrane. ATG9A oligomerization helps its sorting through biosynthetic compartments. |
Sequential deletions and point mutations, immunofluorescence localization in HeLa cells, co-transfection rescue experiments |
Biochimica et biophysica acta |
Medium |
27316455
|
| 2020 |
The SNX4–SNX7 heterodimer is an autophagy-specific SNX-BAR complex required for efficient ATG9A trafficking from the Golgi region to sites of autophagosome assembly. SNX4 disruption causes mis-trafficking/retention of ATG9A in the Golgi region and impairs LC3 lipidation and autophagosome assembly. |
siRNA and CRISPR-Cas9 KO of SNX4, immunofluorescence of ATG9A localization, LC3 lipidation assay, autophagosome assembly imaging |
Journal of cell science |
Medium |
32513819
|
| 2021 |
SNX4 mediates recycling of ATG9A from endolysosomes to early endosomes, from where ATG9A is recycled to the TGN in a retromer-dependent (VPS35-dependent) manner. SNX4 depletion causes ATG9A accumulation on endolysosomes and inhibits starvation-induced autophagosome biogenesis and autophagic flux. |
siRNA depletion of SNX4/VPS35, immunofluorescence of ATG9A on endolysosomes/early endosomes, autophagy flux assay |
Journal of cell science |
Medium |
33468622
|
| 2020 |
ATG9A localizes to neurons of the mouse CNS, particularly highly expressed in Purkinje cells where it is found in the ER, TGN, lysosomes/late endosomes, and axon terminals, as determined by immunohistochemistry with a specific antibody recognizing both non-glycosylated (~94 kDa) and glycosylated (~105 kDa) forms. |
Antibody production, immunohistochemistry, subcellular fractionation/immunoblotting |
The journal of histochemistry and cytochemistry |
Medium |
20124090
|
| 2014 |
miR-34a directly binds the ATG9A 3'-UTR but not a mutated version, inhibiting ATG9A protein expression and autophagic activity in cardiomyocytes. ATG9A overexpression or Ang II treatment upregulates autophagic activity and cardiomyocyte hypertrophy; ATG9A knockdown reverses these effects, placing ATG9A downstream of miR-34a in the regulation of cardiac hypertrophy. |
3'-UTR luciferase reporter assay, miR-34a overexpression/inhibition, ATG9A knockdown/overexpression, autophagy assays (LC3 II/I, p62, TEM, flow cytometry) |
PloS one |
Medium |
24728149
|
| 2020 |
ATG9A interacts with F-actin and NMMHC IIA in response to oxygen-glucose deprivation/reoxygenation (OGD/R). NMMHC IIA-actin interaction contributes to ATG9A trafficking and autophagosome formation. Inhibition of NMMHC IIA (blebbistatin) or F-actin polymerization (cytochalasin D) suppresses ATG9A trafficking and autophagy induction. |
Co-IP (NMMHC IIA–ATG9A–F-actin), siRNA knockdown, blebbistatin/cytochalasin D treatment, ATG9A trafficking assay, mouse MCAO model |
Cell death & disease |
Medium |
32513915
|
| 2025 |
ATG9A-containing vesicles deliver PI4K2A to damaged lysosomes, playing a critical role in lysosome repair. ARFIP2, a component of ATG9A vesicles, binds and sequesters PI4P on lysosomes, balancing OSBPL-dependent lipid transfer and promoting retrieval of ATG9A vesicles through AP-3 recruitment. |
ATG9A KO cells, live-cell imaging of ATG9A vesicle dynamics upon lysosomal damage, Co-IP (ATG9A–ARFIP2–PI4K2A), PI4P assays, intracellular bacterial damage models |
Developmental cell |
Medium |
40460835
|
| 2025 |
ATG9A undergoes S-palmitoylation at Cys155 and Cys156 (2CS mutation abolishes this). S-palmitoylation coordinates ATG9A trafficking from the TGN to phagophores and is required for efficient autophagy initiation. |
Acyl-biotin exchange assay, 2-bromopalmitate inhibition, mutagenesis (2CS), ATG9A trafficking and autophagy initiation assays |
Autophagy |
Medium |
40394978
|
| 2025 |
ATG9A vesicles function as carriers for galectin-9 unconventional secretion, independently of canonical autophagy, secretory autophagy, or LC3-dependent pathways. The N-terminus of ATG9A and both carbohydrate recognition domains of galectin-9 are critical for this process. TMED10 mediates incorporation of galectin-9 into ATG9A vesicles, which fuse with the plasma membrane via the STX13–SNAP23–VAMP3 SNARE complex. ATG9A also regulates secretion of galectin-4, galectin-8, and annexin A6 but not IL-1β, galectin-3, or FGF2. |
ATG9A KO cells, domain mapping (N-terminus mutants), Co-IP (ATG9A–TMED10–galectin-9), SNARE complex identification, galectin secretion assays |
Nature communications |
Medium |
40335523
|
| 2024 |
SEC31a (outer coat protein of COPII vesicles) interacts with ATG9A of autophagosomal seed vesicles, mediating recruitment of COPII vesicles as a membrane source for autophagosome formation during osteogenic differentiation of mesenchymal stem cells. |
Co-IP (SEC31a–ATG9A), SEC31a siRNA in MSCs and in vivo, autophagosome number/size quantification, osteogenesis assay |
Advanced science |
Medium |
39361436
|
| 2024 |
IRP2 (but not IRP1) is required for ATG9A endosomal trafficking. IRP2 ablation results in defective AMPK activation and impaired ATG9A endosomal trafficking, leading to decreased engulfment of NCOA4-ferritin complex by endosomes and dysregulated endosomal microferritinophagy. |
IRP2 KO cells, ATG9A localization assay, ferritinophagy assay (NCOA4-ferritin complex), AMPK activation assay |
The Journal of biological chemistry |
Medium |
39276939
|
| 2024 |
RHOD (atypical Rho GTPase) interacts with ATG9A upon starvation and accompanies ATG9A trafficking from the Golgi toward phagophores. RHOD promotes Golgi fragmentation to facilitate ATG9A vesicle export from the TGN. WHAMM forms a complex with RHOD and participates in ATG9A trafficking in a RHOD-dependent manner. RHOD mutants lacking the exon II effector region (required for ATG9A binding) or the CAAX box fail to stimulate ATG9A trafficking. |
Co-IP (RHOD–ATG9A–WHAMM), BiFC interaction assay, PUP-IT proximity labeling, RHOD KO plus domain-disrupting mutants, ATG9A trafficking assay |
Autophagy |
Medium |
40143438
|
| 2020 |
HIF-1 transcription factor binds the ATG9A promoter under hypoxia. Lentiviral knockdown of ATG9A in intestinal epithelial cells prevents epithelial barrier formation by >95% and causes significant mislocalization of tight junction proteins and defects in the actin cytoskeleton including mislocalization of vasodilator-stimulated phosphoprotein. |
ChIP-chip (HIF-1α antibody + promoter microarray), luciferase promoter assay, HIF-1 KO, lentiviral ATG9A KD, tight junction protein localization, actin cytoskeleton imaging |
Molecular biology of the cell |
Medium |
32726170
|
| 2019 |
ATG9A promotes HIV-1 infectivity in an envelope glycoprotein-dependent manner. ATG9A KO reduces infectivity of WT HIV-1 by ~4–8-fold in HeLa and Jurkat T cells without affecting virus release. Pseudotyping with VSV-G rescues infectivity, and the Nef–ATG9A interaction is not required for this function. |
ATG9A KO (HeLa, Jurkat), virus release assay, infectivity assay, pseudotyping rescue, tandem affinity purification–MS (Nef interactome) |
Retrovirology |
Medium |
31269971
|
| 2016 |
Atg9a deficiency prevents a form of necrosis observed at the bone surface during mouse embryonic development. This necrosis is unaffected by Atg5 KO, establishing Atg9a-dependent necrosis as distinct from canonical autophagy-dependent cell death and indicating an active role for Atg9a in developmental morphogenesis of the bone surface. |
Atg9a KO and Atg5 KO mouse embryos, vital staining with propidium iodide for plasma membrane disruption (in vivo), bone surface morphology analysis |
Nature communications |
Medium |
27811852
|
| 2023 |
In synaptic terminals, ATG9A does not co-assemble into synaptophysin-positive synaptic vesicle condensates but localizes on a distinct class of vesicles that assembles with synapsin into a separate phase. ATG9A undergoes activity-dependent exo-endocytosis at synapses, demonstrating differential sorting of ATG9A vesicles relative to synaptic vesicles. |
Ectopic expression in fibroblasts, live-cell imaging of condensate formation, nerve terminal analysis, activity-dependent exo-endocytosis assay |
Nature communications |
Medium |
36709207
|
| 2024 |
Tepsin directly binds LC3B (but not other mammalian ATG8 family members) via a LIR motif, with micromolar affinity at the established LC3B LIR docking site. Loss of tepsin dysregulates ATG9A export from the TGN and ATG9A distribution at the cell periphery. Reintroduction of tepsin with mutated LIR or missing N-terminus fails to fully rescue ATG9A trafficking defects. |
Biochemical binding assays with purified recombinant proteins, calorimetry, structural modeling, siRNA KD, ATG9A localization assay, mRFP-GFP-LC3B reporter |
Molecular biology of the cell |
Medium |
38381558
|
| 2025 |
ATG9A virtually all resides within a subtype of intracellular nanovesicles (INVs), termed ATG9A-flavor INVs, which constitute ~20% of all INVs. Perturbing ATG9A-flavor INVs impairs the starvation-induced autophagy response. The INV proteome is enriched for transmembrane cargo molecules including integrins and transporters. |
In-cell vesicle capture assays, quantitative imaging analysis of ATG9A co-localization with INV markers, autophagy induction assay upon perturbation |
Journal of cell science |
Low |
40067248
|
| 2023 |
HSF4 directly transcriptionally activates the ATG9a gene in the lens. ChIP assay and luciferase reporter assay confirm HSF4 binding to the ATG9a promoter. Loss of HSF4 reduces ATG9a expression, impairs autophagosome biogenesis, and causes defective organelle clearance in lens fibers. |
ChIP assay, luciferase reporter assay, HSF4 KO mouse (HSF4del42), immunofluorescence and immunoblotting of ATG9a and autophagy markers |
Investigative ophthalmology & visual science |
Low |
37266953
|
| 2023 |
ATG9A supports Chlamydia trachomatis infection via autophagy-independent mechanisms mediated by its binding ability to clathrin adaptor proteins, as shown by rescue experiments with ATG9A mutants defective in clathrin adaptor binding. |
ATG9A-deficient HeLa cells, Chlamydia proliferation assay, rescue with ATG9A mutants defective in clathrin adaptor binding |
Microbiology spectrum |
Low |
37707289
|
| 2025 |
ATG9A interacts with PLA2G6 (iPLA2β). ATG9A–PLA2G6 interaction accelerates phosphatidylcholine degradation, perturbing fatty acid metabolism and causing mitochondrial dysfunction. Liver-specific ATG9A overexpression enhances autophagic flux but impairs autophagosome degradation and disrupts hepatic lipid metabolism. |
Co-IP (ATG9A–PLA2G6), liver-specific ATG9A overexpression mouse model, phosphatidylcholine/fatty acid metabolic assays, mitochondrial function assay |
Autophagy |
Low |
41358570
|
| 2024 |
ATG9A mRNA expression is regulated by m6A modification in arsenic-exposed microglia. FTO (m6A eraser) demethylates ATG9A mRNA, and its loss increases m6A modification and reduces ATG9A expression. ATG9A knockdown significantly attenuates ferritin degradation (ferritinophagy) in arsenic-treated microglial cells. |
m6A sequencing, FTO knockin/KO mouse models, ATG9A siRNA knockdown, ferritinophagy assay |
Journal of hazardous materials |
Low |
40816185
|